HCV-IN-30
CAS No. 1007882-23-6
HCV-IN-30 ( —— )
Catalog No. M26246 CAS No. 1007882-23-6
HCV-IN-30 is an HCV NS5A replication complex inhibitor (IC50s: 901 and 102 nM for genotypes 1a and 1b replicons).
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
10MG | 35 | Get Quote |
|
25MG | 58 | Get Quote |
|
50MG | 87 | Get Quote |
|
100MG | 141 | Get Quote |
|
500MG | 370 | Get Quote |
|
1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameHCV-IN-30
-
NoteResearch use only, not for human use.
-
Brief DescriptionHCV-IN-30 is an HCV NS5A replication complex inhibitor (IC50s: 901 and 102 nM for genotypes 1a and 1b replicons).
-
DescriptionHCV-IN-30 is an HCV NS5A replication complex inhibitor (IC50s: 901 and 102 nM for genotypes 1a and 1b replicons).
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorCDK1/CyclinB; Cdk5/p25; GSK-3β
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1007882-23-6
-
Formula Weight624.8
-
Molecular FormulaC36H44N6O4
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESO=C(N1[C@H](C2=NC=C(C3=CC=C(C4=CC=C(C5=CN=C([C@H](CCC6)N6C(OC(C)(C)C)=O)N5)C=C4)C=C3)N2)CCC1)OC(C)(C)C
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Leclerc S, et al. Indirubins inhibit glycogen synthase kinase-3 beta and CDK5/p25, two protein kinases involved in abnormal tau phosphorylation in Alzheimer's disease. A property common to most cyclin-dependent kinase inhibitors? J Biol Chem. 2001 Jan 5;276(1):251-60.
molnova catalog
related products
-
Cimifugin beta-D-glu...
Prim-O-glucosylcimifugin can inhibit the proliferation of SMC(smooth muscle cell) stimulated by TNF-alpha, increase the proportion of G0/G1 phase.
-
CEBPαinducer1
The compound is a potential inducer of myeloid differentiation via upregulation of C/EBP.
-
Isopropylparaben
Isopropylparaben is a preservative and preservative insecticide.